Literature DB >> 28583409

Portopulmonary hypertension and hepatorenal syndrome. Two faces of the same coin.

Enrico Maria Zardi1, Domenico Maria Zardi2, Chiara Giorgi3, Diana Chin4, Aldo Dobrina5.   

Abstract

Portopulmonary hypertension and hepatorenal syndrome are both severe local hypertensive complications of liver cirrhosis and portal hypertension. Both are characterized by vasoconstrictive manifestations regarding pulmonary and renal vascular network, respectively. This review addresses the mechanisms underlying the development of vasoconstriction that leads to local vascular hypertension in the lung and in the kidney with the result of organ dysfunction. Potential therapeutic options are available for the management of these two syndromes as a bridge for liver transplantation; clinical efficacy depends in part on the time and rapidity of intervention and in part on how serious the chain of events is that has triggered the entire vasoconstrictive process.
Copyright © 2017 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Liver cirrhosis; Oesophageal varices; Portal hypertension

Mesh:

Substances:

Year:  2017        PMID: 28583409     DOI: 10.1016/j.ejim.2017.05.028

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  4 in total

Review 1.  Treatment Barriers in Portopulmonary Hypertension.

Authors:  Batool AbuHalimeh; Michael J Krowka; Adriano R Tonelli
Journal:  Hepatology       Date:  2018-12-18       Impact factor: 17.425

Review 2.  Reappraising the spectrum of AKI and hepatorenal syndrome in patients with cirrhosis.

Authors:  Juan Carlos Q Velez; George Therapondos; Luis A Juncos
Journal:  Nat Rev Nephrol       Date:  2019-11-13       Impact factor: 28.314

3.  An Adult Case of Congenital Extrahepatic Portosystemic Shunt Successfully Treated with Balloon-occluded Retrograde Transvenous Obliteration.

Authors:  Hironori Tanaka; Yoshihito Saijo; Tetsu Tomonari; Takahiro Tanaka; Tatsuya Taniguchi; Shusuke Yagi; Koichi Okamoto; Hiroshi Miyamoto; Masahiro Sogabe; Yasushi Sato; Naoki Muguruma; Koichi Tsuneyama; Masataka Sata; Tetsuji Takayama
Journal:  Intern Med       Date:  2021-01-15       Impact factor: 1.271

4.  Hepatorenal syndrome: role of the transjugular intrahepatic stent shunt in real life practice.

Authors:  Gianni Testino
Journal:  Clujul Med       Date:  2017-10-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.